Vericel Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Vericel Corp 公司

Vericel Corporation 是一家完全整合的商业阶段生物制药公司。该公司为运动医学和严重烧伤护理市场提供先进疗法。它在美国销售三种产品。MACI（猪胶原膜上的自体培养软骨细胞）是一种自体细胞化支架产品，用于修复成人有症状的、一个或多个全层膝关节软骨缺损（无论是否涉及骨骼）。Epicel（培养的自体表皮移植）是一种永久性皮肤替代品，用于治疗深层真皮或全层烧伤面积大于或等于全身表面积 30% 的患者。该公司还持有 NexoBrid（anacaulase-bcdb）的北美权利许可，这是一种含有蛋白水解酶的生物孤儿产品，用于去除成人深层部分厚度和/或全层烧伤的焦痂。

Vericel Corp简介



公司代码VCEL

公司名称Vericel Corp

上市日期Feb 04, 1997

CEOMr. Dominick C. Colangelo

员工数量357

证券类型Ordinary Share

年结日Feb 04

公司地址64 Sidney St

城市CAMBRIDGE

上市交易所NASDAQ Global Market Consolidated

国家United States of America

邮编02139

电话17349305555

网址https://vcel.com/

公司代码VCEL

上市日期Feb 04, 1997

CEOMr. Dominick C. Colangelo

Vericel Corp公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Dominick C. Colangelo

President, Chief Executive Officer, Director

260.28K

--

Dr. Jonathan Mark Hopper

Chief Medical Officer

66.21K

--

Mr. Alan L. Rubino

Independent Director

45.99K

+7.48%

Dr. Paul K. Wotton, Ph.D.

Independent Director

30.60K

+11.68%

Dr. Robert L. Zerbe, M.D.

Independent Chairman of the Board

29.80K

+12.03%

Mr. Michael Halpin

Chief Operating Officer

15.63K

+2.77%

Mr. Kevin F. Mclaughlin

Independent Director

15.10K

--

Ms. Lisa Wright

Independent Director

12.65K

+33.86%

Mr. Sean C. Flynn

Chief Legal Officer

971.00

+105.29%

Ms. Heidi M. Hagen

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Dominick C. Colangelo

President, Chief Executive Officer, Director

260.28K

--

Dr. Jonathan Mark Hopper

Chief Medical Officer

66.21K

--

Mr. Alan L. Rubino

Independent Director

45.99K

+7.48%

Dr. Paul K. Wotton, Ph.D.

Independent Director

30.60K

+11.68%

Dr. Robert L. Zerbe, M.D.

Independent Chairman of the Board

29.80K

+12.03%

Mr. Michael Halpin

Chief Operating Officer

15.63K

+2.77%

收入明细

单位: USD更新时间: 10月6日周一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

MACI

53.46M

84.53%

Epicel

8.61M

13.62%

NexoBrid

1.17M

1.85%

地区USD

名称

营收

占比

United States

63.24M

100.00%

业务

地区

业务USD

名称

营收

占比

MACI

53.46M

84.53%

Epicel

8.61M

13.62%

NexoBrid

1.17M

1.85%

股东统计

更新时间: 8月15日周五

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.89%

The Vanguard Group, Inc.

7.04%

Brown Capital Management, LLC

5.57%

State Street Investment Management (US)

4.83%

Conestoga Capital Advisors, LLC

4.31%

其他

64.36%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

13.89%

The Vanguard Group, Inc.

7.04%

Brown Capital Management, LLC

5.57%

State Street Investment Management (US)

4.83%

Conestoga Capital Advisors, LLC

4.31%

其他

64.36%

股东类型

持股股东

占比

Investment Advisor

65.78%

Investment Advisor/Hedge Fund

38.20%

Pension Fund

2.78%

Research Firm

2.56%

Hedge Fund

1.37%

Bank and Trust

1.08%

Individual Investor

1.06%

Insurance Company

0.10%

Sovereign Wealth Fund

0.05%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

543

56.93M

112.82%

-720.71K

2025Q2

541

57.26M

113.48%

+428.24K

2025Q1

559

55.34M

109.94%

-1.25M

2024Q4

543

54.07M

108.22%

-1.11M

2024Q3

519

52.64M

107.39%

-2.94M

2024Q2

509

52.53M

108.12%

-3.27M

2024Q1

499

52.78M

109.13%

-3.92M

2023Q4

473

53.52M

112.14%

-4.39M

2023Q3

463

53.25M

111.77%

-4.17M

2023Q2

465

51.63M

108.55%

-6.73M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

7.01M

13.89%

-253.88K

-3.50%

Jun 30, 2025

The Vanguard Group, Inc.

3.55M

7.04%

+69.96K

+2.01%

Jun 30, 2025

Brown Capital Management, LLC

2.81M

5.57%

-70.14K

-2.43%

Jun 30, 2025

State Street Investment Management (US)

2.44M

4.83%

-1.72K

-0.07%

Jun 30, 2025

Conestoga Capital Advisors, LLC

2.46M

4.88%

+401.99K

+19.50%

Jun 30, 2025

Fidelity Management & Research Company LLC

1.97M

3.91%

-216.21K

-9.88%

Jun 30, 2025

Geneva Capital Management LLC

1.78M

3.54%

+419.18K

+30.69%

Jun 30, 2025

Invesco Advisers, Inc.

1.77M

3.51%

-214.40K

-10.80%

Jun 30, 2025

Congress Asset Management Company, LLP

1.74M

3.45%

+265.61K

+17.99%

Jun 30, 2025

GW&K Investment Management, LLC

1.41M

2.8%

-17.89K

-1.25%

Jun 30, 2025

持股ETF



更新时间: 10月6日周一

机构名称

占比

Invesco S&P SmallCap Health Care ETF

1.24%

ALPS Medical Breakthroughs ETF

1.07%

SPDR S&P Biotech ETF

0.42%

First Trust NASDAQ Pharmaceuticals ETF

0.37%

Invesco S&P SmallCap 600 Pure Growth ETF

0.35%

WisdomTree BioRevolution Fund

0.26%

SPDR S&P 600 Small Cap Growth ETF

0.26%

Direxion Daily S&P Biotech Bull 3X Shares

0.25%

OneAscent Small Cap Core ETF

0.25%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.25%

Invesco S&P SmallCap Health Care ETF

占比1.24%

ALPS Medical Breakthroughs ETF

占比1.07%

SPDR S&P Biotech ETF

占比0.42%

First Trust NASDAQ Pharmaceuticals ETF

占比0.37%

Invesco S&P SmallCap 600 Pure Growth ETF

占比0.35%

WisdomTree BioRevolution Fund

占比0.26%

SPDR S&P 600 Small Cap Growth ETF

占比0.26%

Direxion Daily S&P Biotech Bull 3X Shares

占比0.25%

OneAscent Small Cap Core ETF

占比0.25%

Vanguard S&P Small-Cap 600 Growth Index Fund

占比0.25%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据